688506 Stock Overview
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥199.09 |
| 52 Week High | CN¥238.80 |
| 52 Week Low | CN¥96.21 |
| Beta | 0 |
| 11 Month Change | 0.85% |
| 3 Month Change | 9.05% |
| 1 Year Change | 86.07% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 521.19% |
Recent News & Updates
Solid Earnings Reflect Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Strength As A Business
Nov 04
Getting In Cheap On Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE:688506) Is Unlikely
Oct 29Recent updates
Solid Earnings Reflect Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Strength As A Business
Nov 04Getting In Cheap On Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE:688506) Is Unlikely
Oct 29Sichuan Biokin PharmaceuticalLtd (SHSE:688506) Could Easily Take On More Debt
Aug 17Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Earnings May Just Be The Starting Point
May 03Shareholder Returns
| 688506 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.6% | -5.2% | -4.1% |
| 1Y | 86.1% | -6.7% | 3.8% |
Return vs Industry: 688506 exceeded the CN Pharmaceuticals industry which returned -6.7% over the past year.
Return vs Market: 688506 exceeded the CN Market which returned 3.8% over the past year.
Price Volatility
| 688506 volatility | |
|---|---|
| 688506 Average Weekly Movement | 10.1% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688506 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688506's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,264 | Yi Zhu | www.baili-pharm.com |
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary
| 688506 fundamental statistics | |
|---|---|
| Market cap | CN¥79.84b |
| Earnings (TTM) | CN¥3.80b |
| Revenue (TTM) | CN¥5.85b |
21.0x
P/E Ratio13.7x
P/S RatioIs 688506 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688506 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.85b |
| Cost of Revenue | CN¥272.85m |
| Gross Profit | CN¥5.57b |
| Other Expenses | CN¥1.77b |
| Earnings | CN¥3.80b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.48 |
| Gross Margin | 95.33% |
| Net Profit Margin | 64.99% |
| Debt/Equity Ratio | 36.2% |
How did 688506 perform over the long term?
See historical performance and comparison